RAS pathway activation and microenvironmental adaptation as hallmarks of myeloid sarcoma
RNA-seq (gene expression) · human · 108 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Acute myeloid leukemiaThis series is part of our curated briefing on it.
- Samples
- 108 samples: 105 distinct titles, 1 of them repeatedGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE279256_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1171728. Searching any of these in the dataset finder brings you back here.
How we read this: Read from 108 sample titles: 105 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8565272 Pt_8_MS-1
- GSM8565273 Pt_8_MS-2
- GSM8565274 Pt_2_MS
- GSM8565275 Pt_8_MS-3
- GSM8565276 Pt_8_MS-4
- GSM8565277 Pt_9A_MS
- GSM8565278 Pt_10_MS
- GSM8565279 Pt_16_MS
- GSM8565280 Pt_20_MS
- GSM8565281 Pt_24_MS
- GSM8565282 Pt_8_BM
- GSM8565283 Ct_Pt_B
- GSM8565284 Ct_Pt_C
- GSM8565285 Ct_Pt_D
- GSM8565286 Ct_AML_E
- GSM8565287 Ct_AML_F
- GSM8565288 Ct_AML_G
- GSM8565289 Ct_AML_H
- GSM8565290 Ct_AML_I
- GSM8565291 Ct_AML_J
- GSM8565292 Ct_AML_K
- GSM8565293 Ct_AML_L
- GSM8565294 Pt_2_BM
- GSM8565295 Pt_10_BM
- GSM8565296 Pt_10_BM_CR
- GSM8565297 Pt_20_BM
- GSM8565298 Pt_24_BM
- GSM8565299 Pt_16_BM
- GSM8565300 Pt_5_BM
- GSM8565301 Pt_9_BM
- GSM8565302 Pt_6_BM
- GSM8565303 Pt_21_BM
- GSM8565304 Pt_22_BM
- GSM8565305 Pt_23_BM
- GSM8565306 Pt_26A_BM
- GSM8565307 Pt_29_BM
- GSM8565308 Pt_31_BM
- GSM8565309 Pt_32_BM
- GSM8565310 Pt_35_BM
- GSM8565311 Pt_36_BM
+ 68 more — browse all 108 samples with per-sample file links →
- GSE137851 The long non-coding RNA HOXB-AS3 regulates ribosomal RNA transcription in NPM1-mutated acute myeloid leukemia 387 samples same disease briefing · shares myeloid
- GSE270185 Repurposing CD19-directed immunotherapies for pediatric t(8;21) acute myeloid leukemia 249 samples same disease briefing · shares myeloid
- GSE303795 Halofuginone exerts broad-spectrum cytotoxic effects by regulating p-eIF2α-S100A8/A9-calcium signaling, inhibiting global protein synthesis, and reversing the resistance of idarubicin in acute myeloid leukemia 6 samples same disease briefing · shares myeloid
- GSE137574 Kevetrin induces apoptosis in TP53 wild-type and mutant acute myeloid leukemia cells 24 samples same disease briefing · shares myeloid
- GSE129437 Genome-wde mapping of BRD9 binding sites and gene expression changes upon BRD9 knockdown 6 samples same disease briefing
- GSE122515 Bonn Dataset 3 of meta-analysis on AML classification, RNAseq dataset 0 samples same disease briefing
- GSE281506 Combining Menin and MEK inhibition to target poor prognosis KMT2A-rearranged RAS pathway-mutant acute myeloid leukemia 42 samples shares ras, myeloid
- GSE324062 RAS pathway activation drives clonal selection and monocytic differentiation in FLT3 and BCL2 inhibitor resistance 61 samples shares ras, activation
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.